Please check your internet connection and try again.
# Cystone Forte
## Overview
Cystone Forte is a proprietary Ayurvedic polyherbal formulation (Himalaya Wellness Company) marketed primarily for nephrolithiasis (kidney stones) and urinary tract health. It is a concentrated version of the standard Cystone formulation. Because it is a botanical supplement, product standardization, bioavailability, and regulatory oversight vary significantly compared to conventional pharmaceuticals.
## Primary Indications
* Prophylaxis and treatment of urolithiasis (metabolic, idiopathic, or crystalluria).
* Adjuvant therapy in urinary tract infections (UTIs).
* Management of burning micturition (dysuria) and non-specific urethritis.
## Adult Dosing
* **Renal Calculi/Crystalluria:** 1 tablet twice daily.
* **Urinary Tract Infections:** 1 tablet twice daily for 7–14 days.
* *Note:* Specific local protocols or clinical trial guidelines for this "Forte" formulation are limited; duration is typically determined by the resolution of symptoms and clinical imaging.
## Pediatric Dosing
* **Safety Warning:** Pediatric dosing is not standardized for the Forte formulation.
* *Clinical Recommendation:* Should be avoided in pediatric patients unless explicitly directed by a specialized practitioner. The standard (non-Forte) Cystone is sometimes used in pediatrics, but the higher concentration in the Forte version increases the risk of toxicity or adverse reactions in younger patients.
## Dose Adjustments
* **Renal Impairment:** Not specifically studied. Use with extreme caution, as the product is intended to treat renal conditions, and compromised clearance may alter steady-state concentrations.
* **Hepatic Impairment:** No established guidelines; use caution.
## Contraindications
* Hypersensitivity to any of the herbal components (*Didymocarpus pedicellata, Saxifraga ligulata, Rubia cordifolia*, etc.).
* Severe renal failure or obstruction requiring emergency surgery.
* Pregnancy/Lactation: Safety data is insufficient; use is generally discouraged.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, or abdominal discomfort.
* **Dermatological:** Rare allergic skin rashes.
* **Systemic:** Potential for heavy metal contamination inherent in uncontrolled herbal supplements; monitor for unexplained systemic symptoms.
## Key Drug Interactions
* **Diuretics:** Potential additive effect on urinary flow, requiring monitoring for electrolyte imbalances.
* **Urinary Alkalinizers/Acidifiers:** May interfere with the pharmacodynamics of the drug’s potential to alter urine pH.
* **Systemic Medications:** As with many herbal products, potential inhibition or induction of CYP450 enzymes is unknown. Consult with a pharmacist if the patient is on narrow-therapeutic-index drugs (e.g., warfarin, phenytoin, digoxin).
## Monitoring
* **Clinical:** Monitor for stone passage, reduction in dysuria, or resolution of UTI symptoms.
* **Laboratory:** Serial urinalysis (to check for crystalluria or UTI resolution) and serum creatinine (if kidney function is unstable).
* **Imaging:** Follow-up ultrasound or CT scan as directed by nephrology/urology.
## Clinical Pearls
* **Not a Replacement for Antibiotics:** For acute bacterial UTIs, Cystone Forte is an *adjuvant* and should not delay antibiotic therapy.
* **Hydration:** Maintain high fluid intake (2–3 liters daily) to maximize the therapeutic benefit of lithotropic agents.
* **Evidence Gap:** Large-scale, double-blind, randomized controlled trials are lacking for the "Forte" iteration compared to standard pharmaceuticals. Rely on standard of care (e.g., fluid intake, shockwave lithotripsy, or surgical intervention) for acute symptomatic stones.
***
**Educational Disclaimer:** This information is for educational purposes only. Cystone Forte is a proprietary herbal supplement and is not FDA-approved as a drug. Dosing and clinical usage can vary by manufacturer and regional clinical guidelines. Always consult the product label, a licensed healthcare provider, or a local clinical pharmacist to verify current safety data and prescribing information before initiating therapy.